Your browser doesn't support javascript.
loading
Delay in initiation of adjuvant trastuzumab therapy leads to decreased overall survival and relapse-free survival in patients with HER2-positive non-metastatic breast cancer.
Gallagher, Christopher M; More, Kenneth; Kamath, Tripthi; Masaquel, Anthony; Guerin, Annie; Ionescu-Ittu, Raluca; Gauthier-Loiselle, Marjolaine; Nitulescu, Roy; Sicignano, Nicholas; Butts, Elizabeth; Wu, Eric Q; Barnett, Brian.
Afiliação
  • Gallagher CM; Washington Cancer Institute, MedStar Washington Hospital Center, 110 Irving Street, NW, Room C-2149, Washington, DC, 20010-2975, USA. Christopher.Gallagher@medstar.net.
  • More K; Virginia Oncology Associates, Virginia Beach, VA, USA.
  • Kamath T; Genentech, Inc., South San Francisco, CA, USA.
  • Masaquel A; Genentech, Inc., South San Francisco, CA, USA.
  • Guerin A; Analysis Group, Inc., Montreal, QC, Canada.
  • Ionescu-Ittu R; Analysis Group, Inc., Montreal, QC, Canada.
  • Gauthier-Loiselle M; Analysis Group, Inc., Montreal, QC, Canada.
  • Nitulescu R; Analysis Group, Inc., Montreal, QC, Canada.
  • Sicignano N; Health ResearchTx LLC, Trevose, VA, USA.
  • Butts E; Navy and Marine Corps Public Health Center, Portsmouth, VA, USA.
  • Wu EQ; Navy and Marine Corps Public Health Center, Portsmouth, VA, USA.
  • Barnett B; Analysis Group, Inc., Boston, MA, USA.
Breast Cancer Res Treat ; 157(1): 145-56, 2016 05.
Article em En | MEDLINE | ID: mdl-27107569
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Trastuzumab / Antineoplásicos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Trastuzumab / Antineoplásicos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos